The Journal of Pain
Volume 11, Issue 1 , Pages 24-31 , January 2010

A Multicenter, Open-Label, Exploratory Dose-Ranging Trial of Intranasal Hydromorphone for Managing Acute Pain from Traumatic Injury

  • Daniel P. Wermeling

      Affiliations

    • Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky College of Pharmacy, Lexington, Kentucky
    • Corresponding Author InformationAddress reprint requests to Dr. Daniel Wermeling, Associate Professor, University of Kentucky College of Pharmacy, 725 Rose Street, Lexington, KY 40536-0082.
    • ,
  • Thomas Clinch

      Affiliations

    • Intranasal Therapeutics, Inc., Lexington, Kentucky
    • ,
  • Anita C. Rudy

      Affiliations

    • Intranasal Therapeutics, Inc., Lexington, Kentucky
    • ,
  • David Dreitlein

      Affiliations

    • Department of Emergency Medicine, Montrose Memorial Hospital, Montrose, Colorado
    • ,
  • Selim Suner

      Affiliations

    • Associate Professor of Emergency Medicine, Surgery, and Engineering, Brown University, Providence, Rhode Island
    • Director of Emergency Preparedness and Disaster Medicine, Department of Emergency Medicine, Rhode Island Hospital, Providence, Rhode Island
    • ,
  • Peter G. Lacouture

      Affiliations

    • Magidom Discovery, Tampa, Florida

Received 5 February 2009 ,Revised 23 April 2009 ,Accepted 22 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The multicenter study was supported by grants from Intranasal Therapeutics, Inc. The following information is provided as a statement of potential conflicts of interest. Drs. Wermeling and Lacouture were paid consultants to Intranasal Therapeutics, Inc., at the time of this research. Drs. Wermeling and Rudy and Mr. Clinch own stock options in Intranasal Therapeutics. Drs. Lacouture, Dreitlein and Suner have no conflicts to disclose.

PII: S1526-5900(09)00547-1

doi: 10.1016/j.jpain.2009.05.002

The Journal of Pain
Volume 11, Issue 1 , Pages 24-31 , January 2010

Article Tools

* Image Usage & Resolution